BEGIN:VCALENDAR VERSION:2.0 PRODID:unctad.org BEGIN:VEVENT UID:6aa84a11970cb DTSTART:20180716T061500Z SEQUENCE:0 TRANSP:OPAQUE DTEND:20180716T074500Z LOCATION:New York\, États-Unis d'\;Amérique SUMMARY:BioTrade\, Access and Benefit Sharing and SDG 15 CLASS:PUBLIC DESCRIPTION:​This roundtable event will provide a critical analysis on ho w trade\, and BioTrade and the ABS Mechanism under the Nagoya Protocol\, c an be incentives for the achievement of several SDGs\, especially SDG 15 b y promoting benefit sharing\, and sustainable trade and livelihoods with t he ultimate objective of reducing biodiversity loss. Several developing an d least developed countries have identified biological and genetic resourc es as an economic asset and embarked on transforming their production and export-base towards biodiversity friendly sectors\, products\, and service s. Many of them have also ratified and started implementation of the Nagoy a Protocol. This contributes not only to conserve and sustainably use biod iversity but also to increase legal certainty\, employment\, technology tr ansfer\, business opportunities and income for SMEs and local communities\ , particularly those rich in biodiversity.The event is organized with the support of the Swiss State Secretariat for Economic Affairs SECO under the Global BioTrade Programme: Linking trade\, environment and sustainable de velopment and the German Federal Ministry for Economic Cooperation and Dev elopment (BMZ).BackgroundFor two decades\, BioTrade and its partners and b eneficiaries in Africa\, Asia\, Latin America and Europe have contributed to enhancing environmental\, social and economic sustainability through th e trade of biodiversity-based goods and services. This has generated initi atives that use their surrounding biodiversity\, going beyond traditional agricultural crops and livestock\, to develop and trade value added produc ts. Moreover\, BioTrade is increasing the economic self-reliance and resil ience of communities and SMEs\, mainstreaming biodiversity and ABS\, while safeguarding biodiversity. Consequently\, BioTrade contributes directly a nd indirectly to 94% of the SDGs.Though only 4% of world trade (US$290 bil lion) is related to biodiversity-based goods and services (Gomez-García e t al\, 2014)\, the market has shown astonishing growth in past decades and is continuing to grow at a rapid pace. For instance\, the growth of the n atural product sales increased from US$1.9 billion in 1980\, to US$141 bil lion in 2016 (New Hope Network\, 13 July 2017)\, provided stimulus for com panies to shift towards socially and environmentally friendly production p rocesses. More significantly\, sales from BioTrade beneficiary companies a nd associations have reached Euro 4.44 billion (US$5.38 billion) in 2016 i n over 3500 value chains in Africa\, Asia\, Latin America and Europe\, ill ustrating a significant increase from US$ 30 million in 2003.Today\, more than 105 countries have ratified the Nagoya Protocol. Well-designed Nagoya -compliant BioTrade value chains\, framed by enabling Access and Benefit-s haring (ABS) regimes are fostering a range of Agenda 2030 Goals with the t arget 6 of SDG 15 at its core. Access and Benefit-sharing (ABS) is directl y related to poverty alleviation\, (1.4)\, food security (2.5)\, health (3 .b)\, economic growth (8.3)\, infrastructural development (9.5\, 9.5b)\, c limate change adaptation (13.1)\, marine conservation (14.7\, 14.7a)\, ter restrial conservation (15.a)\, peace and justice (16.3\, 16.6)\, and globa l partnerships (17.3\, 17.7\, 17.9\, 17.17\, 17.15).In response to the wor ldwide consumer and market trends of “more natural” and “more tracea ble” products and services such as those in the food\, body care and pha rmaceutical sectors\, R&\;D and innovation-oriented projects with stron g monitoring components are on the rise. Increasingly\, BioTrade companies tend to engage in R&\;D at the higher level of the value chain and the refore potentially trigger ABS regulations. Recent experiences in countrie s such as South Africa\, Peru\, and Viet Nam show that there is flexibilit y and various models and options to create incentives for compliance and s haring of benefits for all parties involved.<\;p>\;​This roundtable event will provide a critical analysis on how trade\, and BioTrade and the ABS Mechanism under the Nagoya Protocol\, can be incentives for the achie vement of several SDGs\, especially SDG 15 by promoting benefit sharing\, and sustainable trade and livelihoods with the ultimate objective of reduc ing biodiversity loss. Several developing and least developed countries ha ve identified biological and genetic resources as an economic asset and em barked on transforming their production and export-base towards biodiversi ty friendly sectors\, products\, and services. Many of them have also rati fied and started implementation of the Nagoya Protocol. This contributes n ot only to conserve and sustainably use biodiversity but also to increase legal certainty\, employment\, technology transfer\, business opportunitie s and income for SMEs and local communities\, particularly those rich in b iodiversity.<\;/p>\;<\;p>\;The event is organized with the support of the Swiss State Secretariat for Economic Affairs SECO under the Global BioTrade Programme&\;#58\; Linking trade\, environment and sustainable development and the German Federal Ministry for Economic Cooperation and Development (BMZ).<\;/p>\;<\;p>\;<\;strong>\;Background<\;/s trong>\;<\;/p>\;<\;p>\;For two decades\, BioTrade and its partne rs and beneficiaries in Africa\, Asia\, Latin America and Europe have cont ributed to enhancing environmental\, social and economic sustainability th rough the trade of biodiversity-based goods and services. This has generat ed initiatives that use their surrounding biodiversity\, going beyond trad itional agricultural crops and livestock\, to develop and trade value adde d products. Moreover\, BioTrade is increasing the economic self-reliance a nd resilience of communities and SMEs\, mainstreaming biodiversity and ABS \, while safeguarding biodiversity. Consequently\, BioTrade contributes di rectly and indirectly to 94% of the SDGs.<\;/p>\;<\;p>\;Though onl y 4% of world trade (US$290 billion) is related to biodiversity-based good s and services (Gomez-García et al\, 2014)\, the market has shown astonis hing growth in past decades and is continuing to grow at a rapid pace. For instance\, the growth of the natural product sales increased from US$1.9 billion in 1980\, to US$141 billion in 2016 (New Hope Network\, 13 July 20 17)\, provided stimulus for companies to shift towards socially and enviro nmentally friendly production processes. More significantly\, sales from B ioTrade beneficiary companies and associations have reached Euro 4.44 bill ion (US$5.38 billion) in 2016 in over 3500 value chains in Africa\, Asia\, Latin America and Europe\, illustrating a significant increase from US$ 3 0 million in 2003.<\;/p>\;<\;p>\;Today\, more than 105 countries h ave ratified the Nagoya Protocol. Well-designed Nagoya-compliant BioTrade value chains\, framed by enabling Access and Benefit-sharing (ABS) regimes are fostering a range of Agenda 2030 Goals with the target 6 of SDG 15 at its core. Access and Benefit-sharing (ABS) is directly related to poverty alleviation\, (1.4)\, food security (2.5)\, health (3.b)\, economic growt h (8.3)\, infrastructural development (9.5\, 9.5b)\, climate change adapta tion (13.1)\, marine conservation (14.7\, 14.7a)\, terrestrial conservatio n (15.a)\, peace and justice (16.3\, 16.6)\, and global partnerships (17.3 \, 17.7\, 17.9\, 17.17\, 17.15).<\;/p>\;<\;p>\;In response to the worldwide consumer and market trends of “more natural” and “more tra ceable” products and services such as those in the food\, body care and pharmaceutical sectors\, R&\;D and innovation-oriented projects with st rong monitoring components are on the rise. Increasingly\, BioTrade compan ies tend to engage in R&\;D at the higher level of the value chain and therefore potentially trigger ABS regulations. Recent experiences in count ries such as South Africa\, Peru\, and Viet Nam show that there is flexibi lity and various models and options to create incentives for compliance an d sharing of benefits for all parties involved.<\;/p>\;\n\nView meetin g on unctad.org\nhttps://unctad.org/meeting/biotrade-access-and-benefit-sh aring-and-sdg-15 DTSTAMP:20260914T192505Z END:VEVENT END:VCALENDAR